ARTICLE | Company News

Biophage Inc., Immune Network Research Ltd. deal

January 31, 2000 8:00 AM UTC

The companies will develop IMM's 1F7 antibody to treat AIDS and an undisclosed Biophage antibody. The companies plan to fund and own the compounds jointly. IMM plans to start a Phase I/II trial of 1F7 in the second half of the year. ...